New partnership with 2cureX
We are proud to announce that we have become the exclusive distributor of 2cureX for Czechia and Slovakia.
2cureX is a leader in the field of cancer drug susceptibility testing and has developed the IndiTreat® (individual treatment) range of tests. IndiTreat® is based on a sample of the patient’s tumor, generates thousands of 3D replicas (tumorroids) and predicts the tumor’s response to various available drugs, providing valuable information to the physician for treatment decisions.
“The addition of IndiTreat® to our diagnostic and pharmaceutical product offerings provides our sales team with another very powerful and innovative solution for patients and their physicians. As a market leader, it is important for us to continuously offer cutting-edge healthcare solutions,” said Pavel Hanuš, CEO of Promedica.
We look forward to a fruitful cooperation!